Universal-Beteiligungs- und Servicegesellschaft’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.75M Buy
125,689
+16,051
+15% +$710K 0.01% 813
2026
Q1
$5.28M Buy
109,638
+26,586
+32% +$1.82M 0.01% 845
2025
Q4
$5.78M Buy
83,052
+67,338
+429% +$2.75M 0.01% 825
2025
Q3
$440K Buy
15,714
+3,800
+32% +$75.7K ﹤0.01% 1784
2025
Q2
$247K Sell
11,914
-64,949
-84% -$1.43M ﹤0.01% 1882
2025
Q1
$1.33M Sell
76,863
-37,129
-33% -$910K ﹤0.01% 1372
2024
Q4
$3.09M Buy
+113,992
New +$4.04M 0.01% 826

Other funds holding GPCR

Universal-Beteiligungs- und Servicegesellschaft's GPCR Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Structure Therapeutics (GPCR) stake by 15% in Q2 2026, buying an estimated $710K and bringing the position to 125,689 shares worth $6.75M. The position accounts for 0.01% of the portfolio, ranked #813.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in GPCR in Q4 2024 and has held it in 7 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 125,689 shares of Structure Therapeutics worth $6.75M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 16,051 Structure Therapeutics shares in Q2 2026, an estimated $710K.
  • Structure Therapeutics made up 0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #813 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Structure Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.